Compugen | CGEN - Capital Ordinário





Capital Ordinário Alterar Data
Arca Biopharma USD 48.72M 338K 2025-12
aTyr Pharma USD 16.65M 81.34M 2025-12
Bio Path USD 9.24M 934K 2025-09
Brainstorm Cell Therapeutics USD 11.03M 913K 2025-09
Cara Therapeutics USD 2K 3K 2025-03
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
Immunic USD 8K 4K 2024-06
Infinity Pharmaceuticals USD 90K 1000 2023-06
Minerva Neurosciences USD 1000 0 2024-09
RedHill Biopharma USD 33.3B 20.4B 2025-06
TherapeuticsMD USD 11K 0 2023-09